Details of Host Protein
Host Protein General Information (ID: PT1261) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Protein Name |
YTH domain-containing family protein 2 (YTHDF2)
|
Gene Name |
YTHDF2
|
||||||
Host Species |
Homo sapiens
|
Uniprot Entry Name |
YTHD2_HUMAN
|
||||||
Protein Families |
YTHDF family
|
||||||||
Subcellular Location |
Cytoplasm; cytosol Cytoplasm; P-body Cytoplasm
|
||||||||
External Link | |||||||||
NCBI Gene ID | |||||||||
Uniprot ID | |||||||||
Ensembl ID | |||||||||
HGNC ID | |||||||||
Function in Host |
Specifically recognizes and binds N6-methyladenosine (m6A) -containing RNAs, and regulates their stability. M6A is amodification present at internal sites of mRNAs and some non-codingRNAs and plays a role in mRNA stability and processing. Acts as a regulator of mRNA stability by promotingdegradation of m6A-containing mRNAs via interaction with the CCR4-NOTand ribonuclease P/MRP complexes, depending on the context. The YTHDF paralogs (YTHDF1, YTHDF2 and YTHDF3) sharem6A-containing mRNAs targets and act redundantly to mediate mRNAdegradation and cellular differentiation. M6A-containing mRNAs containing a binding site forRIDA/HRSP12 (5'-GGUUC-3') are preferentially degraded byendoribonucleolytic cleavage: cooperative binding of RIDA/HRSP12 andYTHDF2 to transcripts leads to recruitment of the ribonuclease P/MRPcomplex. Other m6A-containing mRNAs undergodeadenylation via direct interaction between YTHDF2 and CNOT1, leadingto recruitment of the CCR4-NOT and subsequent deadenylation of m6A-containing mRNAs. Required maternally to regulateoocyte maturation: probably acts by binding to m6A-containing mRNAs, thereby regulating maternal transcript dosage during oocyte maturation, which is essential for the competence of oocytes to sustain earlyzygotic development. Also required duringspermatogenesis: regulates spermagonial adhesion by promotingdegradation of m6A-containing transcripts coding for matrixmetallopeptidases. Also involved in hematopoietic stemcells specification by binding to m6A-containing mRNAs, leading topromote their degradation. Also acts as a regulatorof neural development by promoting m6A-dependent degradation of neuraldevelopment-related mRNA targets. Inhibits neuralspecification of induced pluripotent stem cells by binding tomethylated neural-specific mRNAs and promoting their degradation, thereby restraining neural differentiation. Regulatescircadian regulation of hepatic lipid metabolism: acts by promotingm6A-dependent degradation of PPARA transcripts. Regulates the innate immune response to infection by inhibiting thetype I interferon response: acts by binding to m6A-containing IFNBtranscripts and promoting their degradation. May alsoact as a promoter of cap-independent mRNA translation following heatshock stress: upon stress, relocalizes to the nucleus and specificallybinds mRNAs with some m6A methylation mark at their 5'-UTR, protectingdemethylation of mRNAs by FTO, thereby promoting cap-independent mRNAtranslation. Regulates mitotic entry by promoting thephase-specific m6A-dependent degradation of WEE1 transcripts. Promotes formation of phase-separated membranelesscompartments, such as P-bodies or stress granules, by undergoingliquid-liquid phase separation upon binding to mRNAs containingmultiple m6A-modified residues: polymethylated mRNAs act as amultivalent scaffold for the binding of YTHDF proteins, juxtaposingtheir disordered regions and thereby leading to phase separation. The resulting mRNA-YTHDF complexes then partition into differentendogenous phase-separated membraneless compartments, such as P-bodies, stress granules or neuronal RNA granules. May alsorecognize and bind RNAs modified by C5-methylcytosine (m5C) and act asa regulator of rRNA processing.
[1-10]
Click to Show/Hide
|
||||||||
3D Structure |
|
Function of This Protein During Virus Infection | |||||||||
---|---|---|---|---|---|---|---|---|---|
Virus Name | SARS-COV-2 | Protein Function | Anti-viral | [11] | |||||
Infected Tissue | Lung | Infection Time | 7-9 Days | ||||||
Infected Cell | Calu-3 Cells (Human epithelial cell line) | Cellosaurus ID | CVCL_0609 | ||||||
Method Description | To detect the role of host protein YTHDF2 in viral infection, YTHDF2 protein Knockout Calu-3 Cells were infected with SARS-COV-2 for 7 - 9 Days , and the effects on infection was detected through CRISPR-based genome-wide gene-knockout screen. | ||||||||
Results | It is reported that knockout of YTHDF2 increases SARS-CoV-2 RNA levels compared with control group. |
Host Protein - Virus RNA Network | |||||||||
---|---|---|---|---|---|---|---|---|---|
Full List of Virus RNA Interacting with This Protien | |||||||||
---|---|---|---|---|---|---|---|---|---|
RNA Region: Not Specified Virus Region (hCoV-19/Not Specified Virus Strain ) | |||||||||
RNA Region Details | RNA Info Click to show the detail information of this RNA binding region | [12] | |||||||
Strains Name |
hCoV-19/Not Specified Virus Strain
|
||||||||
RNA Binding Region |
Not Specified Virus Region
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | Huh7 cells (liver carcinoma cell) (CVCL_0336 ) | ||||||||
Cell Originated Tissue | Liver | ||||||||
Infection Time | 24h | ||||||||
Interaction Score | log2FC = 1.15863E+14 | ||||||||
Method Description | RNA antisense purification and quantitative mass spectrometry (RAP-MS); Tandem mass tag (TMT) labelling; liquid chromatography tandem mass spectrometry (LC-MS/MS); Westernblot | ||||||||
RNA Region: Not Specified Virus Region (hCoV-19/England/02/2020 ) | |||||||||
RNA Region Details | RNA Info Click to show the detail information of this RNA binding region | [13] | |||||||
Strains Name |
hCoV-19/England/02/2020
|
||||||||
Strains Family |
Beta (B.1.351)
|
||||||||
RNA Binding Region |
Not Specified Virus Region
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | Calu-3 cells (Human lung cancer cell) Calu-3 cells (Human lung cancer cell) (CVCL_0609 ) | ||||||||
Cell Originated Tissue | Lung | ||||||||
Infection Time | 24 h | ||||||||
Interaction Score | P-adjust = 0.006 | ||||||||
Method Description | UV protein-RNA crosslinking; RNA interactome capture (cRIC); RNA antisense purification coupled with mass spectrometry (RAP-MS) |